About Index Trending news
Lists
Pricing
RiverVest

RiverVest

RiverVest

Early-Stage Biotech Investment

Elsewhere

Alexa global traffic share

Twitter followers

Activity

Past year's investments
  • 3 rounds in the past year
  • $99,000,000 deployed in total
  • $33,000,000 avg per round
Latest rounds
  • VentureMed Group, Inc.: Venture capital (Series B) ($15M)
  • Amplyx Pharmaceuticals, Inc: Venture capital (Series C) ($67M)
  • Adarza BioSystems: Venture capital (Series C) ($17M)
Total funding
$34M in 2 rounds from 7 investors
By RiverVest
$10M Series C in Sep, 2016
Total funding
$45.7M in 3 rounds from 3 investors
By RiverVest
$18.4M Series B in Nov, 2014
Total funding
$45M in 1 rounds from 11 investors
By RiverVest
$45M Series C in May, 2006
Total funding
$46M in 1 rounds from 5 investors
By RiverVest
$46M Series D in Oct, 2010
Exit Abbott, Jul 15, 2013
Total funding
$75.7M in 2 rounds from 9 investors
By RiverVest
$67M Series C in Aug, 2017
Total funding
$28.8M in 4 rounds from 6 investors
By RiverVest
$17M Series C in Jan, 2017
Total funding
$86M in 1 rounds from 4 investors
By RiverVest
$86M Series A in Aug, 2016
Total funding
$10M in 1 rounds from 5 investors
By RiverVest
$10M Series C in Sep, 2016
Total funding
$15M in 3 rounds from 4 investors
By RiverVest
$15M Series B in Aug, 2017

Want to see the complete list?
Go Pro!